Sign in

Private company

GemVax & KAEL

GemVax & KAEL is a South Korean company.1

주식회사 젬백스&카엘(영어: GemVax & KAEL)은 반도체 및 디스플레이 산업 현장에 공기오염제어 솔루션을 제공하는 대한민국의 제조 기업이다.2 From the Korean Wikipedia, CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

See how the biggest companies compare on our leaderboards

Calendar

Drug trials and FDA: recently

  1. Oct 11, 2024Phase 2 trial completed Phase 2 trial of GV1001 0.56mg and GV1001 1.12mg in Progressive Supranuclear Palsy: primary completion Oct 11, 2024, results posted Feb 10, 2026 (ClinicalTrials.gov NCT05819658).3

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3